- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Marisa C. Maleck
News 20 results
In the News · Source: The Washington Post
In the News · Source: Law360
July 7, 2021
Marisa Maleck is profiled as a Law360 Rising Star
Recognition
June 1, 2021
Four King & Spalding Lawyers Named Law360 Rising Stars
In the News · Source: Washington DC citybizlist, The Daily Docket, The American Lawyer and Bloomberg Law
January 8, 2021
FDA and Life Sciences partner Marisa Maleck rejoins the firm's Government Matters practice group in Washington, D.C.
Press Release
January 7, 2021
King & Spalding’s FDA and Life Sciences Team Adds Partner in Washington
In the News · Source: Law360
August 7, 2020
Bruce Baber represents Google in U.S. Supreme Court arguments in a copyright dispute with Oracle
In the News · Source: The Washington Post
January 30, 2020
Marisa Maleck discusses Alan Dershowitz's arguments in the Senate impeachment trial
In the News · Source: Law360
In the News · Source: Law360 and The American Lawyer
January 6, 2020
Bruce Baber and Marisa Maleck counsel Google before the Supreme Court in its landmark copyright dispute with Oracle
Press Release
December 5, 2019
King & Spalding Elects 21 New Partners and Promotes Four Counsel Across Eight Offices
In the News · Source: Law360, The National Law Journal and Bloomberg Big Law Business
In the News · Source: Law360
October 16, 2019
Bruce Baber and Marisa Maleck file a supplemental brief on behalf of Google, urging the U.S. Supreme Court to take up its copyright dispute with Oracle